2024-07-2019518.16 KB6页18
2024-07-1919548.5 KB19页27
2024-07-1919515.85 KB2页18
2024-07-191955.59 MB250页4
2024-07-191951.55 MB7页22
2024-07-19195950.99 KB22页15
2024-07-18195759.75 KB8
2024-07-171952.6 MB21页28
2024-07-171951.59 MB32页25
医药小组医疗器械专题时间:2014年3月1日记录人:吕昕蒙个股简单点评:理邦仪器:医用仪器专业性突出乐普:善于利用并购加强专业性,已有7次并购,主营是心血管凯利泰:专业性也不比较突出,关于乐普医疗:支架价格有可能出现反转,12年13年由于政策管控,价格由1万2~1万4跌到现在9千多,现在可能不会再降了,降价压力不大还有一种裸架价格在1万2左右,有可能放量,这种裸架毛利率更高.乐普业务有望触底反弹.另有人见解觉得乐普医疗股东层面,管... 2024-07-17195172.34 KB2页15
EuropeanJournalofHeartFailure(2023)25,457–468POSITIONPAPERdoi:10.1002/ejhf.2814Inotropictherapyinpatientswithadvancedheartfailure.AclinicalconsensusstatementfromtheHeartFailureAssociationoftheEuropeanSocietyofCardiologyFinnGustafsson1,KevinDamman2,SanemNalbantgil3,LindaW.VanLaake4,LaurensF.Tops5,ThomasThum6,StamatisAdamopoulos7,MichaelBonios7,AndrewJSCoats8,MariaG.Crespo-Leiro9,MandeepR.Mehra1... 2024-07-21194687.58 KB12页30
Downloadedfromhttp://ahajournals.orgbyonMarch16,2023CirculationAHASCIENTIFICSTATEMENTEvaluationandManagementofPulmonaryHypertensioninNoncardiacSurgery:AScientificStatementFromtheAmericanHeartAssociationSudarshanRajagopal,MD,PhD,FAHA,ViceChair;KurtRuetzler,MD,PhD,FAHA,Chair;KamrouzGhadimi,MD,MHS,FAHA;EvelynM.Horn,MD;MartaKelava,MD;KristinaT.Kudelko,MD;IngridMoreno-Duarte,MD;IoanaPreston,MD;Leoni... 2024-07-21194990.12 KB27页14
2024-07-2119413.16 MB53页19
2024-07-2119439.98 MB82页4
2024-07-2119418.2 KB3页13
2024-07-21194587.39 KB3页11
2024-07-211944.36 MB2页6
2024-07-21194108.25 KB2页13
2024-07-2119458.67 KB57页11
2024-07-201942 MB256页25